A version of this post first appeared on TKer.co Many popular valuation metrics suggest that the stock market is expensive, implying that investors should expect weak returns over the years to come.
WD-40 (WDFC) stock rated sell: overvaluation above 30x FCF and declining cash flow despite record sales. Read here for an ...
Oscar Health stock (NYSE: OSCR) has recently increased to over $16 after reports of a possible two-year extension of Obamacare subsidies, which may positively influence demand for health insurance via ...
With a Dividend yield of 3.2% in a flat market and a compound profit growth of 108% in the last 5 years, this PSU has proved ...
Stryker (SYK) delivered strong Q3 2025 results, raising full-year guidance on robust organic growth across both MedSurg & Neurotechnology and Orthopaedics segments. SYK achieved double-digit organic ...
The stock boasts the one year return of 34.3%, in contrast to 16.4% for the S&P 500. This situation necessitates a ...
Axon stock is up more than 3,000% over the last decade. The company has built a unique business in law enforcement tech. The business is still growing briskly and expanding into new technologies. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback